Our next Dementia Action Week will take place from 19 - 25 May 2025, where we will continue raise awareness of the importance of a timely and accurate diagnosis for people affected by dementia.

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

More about lecanemab More about donanemab When people can be diagnosed in the earlier stages of dementia and access new disease-modifying treatments, the typical pattern of decline experienced by ...

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.